Dashboard
Poor long term growth as Operating profit has grown by an annual rate 14.74% of over the last 5 years
With a fall in Net Sales of -13.86%, the company declared Very Negative results in Sep 25
39.55% of Promoter Shares are Pledged
Below par performance in long term as well as near term
Stock DNA
Pharmaceuticals & Biotechnology
INR 1,230 Cr (Small Cap)
21.00
34
0.29%
0.13
12.07%
2.56
Total Returns (Price + Dividend) 
Latest dividend: 0.1 per share ex-dividend date: Sep-16-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Sigachi Industries Opens with Weak Start Amid Market Concerns and Gap Down
Sigachi Industries witnessed a significant gap down at the opening of trading today, reflecting ongoing market concerns within the Pharmaceuticals & Biotechnology sector. The stock opened with a loss of 5.8%, extending a recent downward trend amid subdued sector performance and broader market pressures.
Read More
Sigachi Indust. Sees Revision in Market Evaluation Amid Challenging Financial Trends
Sigachi Indust., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation metrics, reflecting shifts in its financial and technical outlook. This adjustment comes amid a backdrop of subdued operational performance and persistent downward pressure on its stock returns.
Read More
Sigachi Industries Technical Momentum Shifts Amid Market Volatility
Sigachi Industries, a player in the Pharmaceuticals & Biotechnology sector, has experienced notable shifts in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across multiple timeframes. The stock’s recent price movements and technical indicators suggest a nuanced market assessment amid broader sector dynamics.
Read More Announcements 
Corporate Actions 
No Upcoming Board Meetings
Sigachi Industries Ltd has declared 10% dividend, ex-date: 16 Sep 25
Sigachi Industries Ltd has announced 1:10 stock split, ex-date: 09 Oct 23
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Non Institution
39.5457
Held by 2 Schemes (0.0%)
Held by 10 FIIs (3.1%)
Rps Industries Private Limited (18.54%)
Rakesh Yadav (2.65%)
47.45%
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is -13.86% vs 0.04% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is 110.65% vs -856.22% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 8.21% vs 19.98% in Sep 2024
Growth in half year ended Sep 2025 is -356.64% vs 34.44% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is 22.12% vs 28.39% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 33.71% vs 16.23% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 22.38% vs 32.08% in Mar 2024
YoY Growth in year ended Mar 2025 is 21.65% vs 31.33% in Mar 2024






